DOI: https://doi.org/10.21203/rs.3.rs-1731767/v1
The primary health care (PHC) in the Alma-Ata Declaration of 1978, revisited in the Astana Declaration of 2018, underpins the fundamental goal of achieving universal healthcare coverage. The 2019 coronavirus pandemic (COVID-19) shows that rapidly spreading outbreaks can significantly hamper the provision of PHC. This study investigates how digital health technologies (DHTs) evolved to support the PHC sector during COVID-19 and lessons for the future improvement of PHC.
A systematic review was conducted through database searches (PubMed, Scopus, and Google Scholar) and hand-searching of grey documents published in English between December 2019 and December 2021. The study employed thematic content analysis and synthesis. The final synthesis included 46 documents: 40 articles; one book; two book chapters; one working paper; and two technical reports. Around 19 major theme categories were found, with the top three being the eHealth category, comprising themes like telemedicine, e-prescription, telepsychiatry, and telehealth visits; the mHealth category, such as App-based telemedicine and mobile electronic patient records connecting patients, physicians, and health systems; and the device category, such as wearable technologies, telemedical stethoscopes, telemedical ECGs, and remote monitoring devices. Finally, 20 areas of use of DHTs were identified and then grouped into five main areas: 1st) provision of health services, such as general care (teleconsultations, diagnosis, testing, etc.) and managing chronic conditions; 2nd) communicating, informing, and educating roles (e.g., preventing vaccine hesitancy) and digital health literacy; 3rd) monitoring and surveillance roles (e.g., symptoms’ monitoring); 4th) vaccination and drug purposes (e.g. e-prescription, adverse-drug-reaction monitoring, etc.); and 5th) enhancing system decision-making.
DHTs have the potential to solve some of the challenges that have plagued us even before COVID-19. Therefore, this study puts forward recommendations to further stimulate the use of evidence based DHT, making it more inclusive, educative, and satisfying to people's needs, both under normal conditions and during outbreaks. More research is required, with a focus on quality assurance in the use of digital health; technical aspects (standards for digital health tools, infrastructure, and platforms); and financial perspectives (payment for digital health services and adoption incentives).
All over the world, the provision of a fairer (equitable), comprehensive, and integrated health care is the aspiration which health care systems strive to achieve. It has been set out in the WHO and UNICEF-defined principle of primary health care (PHC) (1), “a whole-of-society approach to health that aims at ensuring the highest possible level of health and well-being and their equitable distribution by focusing on people’s needs and as early as possible along the continuum from health promotion and disease prevention to treatment, rehabilitation and palliative care, and as close as feasible to people’s everyday environment” (p2).
PHC principles were initially stated in the Alma-Ata Declaration of 1978 (2), which is regarded as a watershed moment in global health. 40 years later, in October 2018, global leaders gathered in Astana, Kazakhstan, for the Global Conference on Primary Health Care (3) to ratify the Astana Declaration (4) for proper PHC delivery. PHC is considered the most efficient and effective strategy for achieving universal health because it focuses on how to effectively deliver health care and services to everyone, everywhere. PHC, on the other hand, differs from the primary care concept, which is often used interchangeably. The shorter term, primary care (PC), refers to a more limited set of “family doctor-type” services provided to individuals (5).
The response to the Sars-Cov-2 pandemic, also known as COVID-19 (6), revealed missed opportunities to provide PHC to all. Many health-care services have been postponed in many countries in order to focus on COVID-19 patients (7, 8). The February 2022 statement of the Association of Schools of Public Health in the European Region (ASPHER), entitled “invest in primary health care and public health for the pandemic and beyond” (9), highlights the typical challenges that health systems have faced in delivering PHC during the COVID-19 pandemic. Although problems have varied depending on the waves, underfunding, and postponing some care services are among the major weaknesses that health systems have experienced. The statement, on the other hand, showed the crucial roles that PHC can play, including in immunization efforts.
Nonetheless, in outbreaks like COVID-19, PHC delivery is hampered by a number of obstacles that must be overcome. While there may be other ways to improve PHC delivery during epidemics and pandemics, DHTs would be among the potential strategies. Thus, understanding how digital health has adapted to PHC delivery for the 2019 coronavirus pandemic around the world is very important.
We sought to thoroughly investigate what happened to digital health in PHC during the COVID-19 pandemic, how it evolved, and what we can learn as a result. We believe that understanding what has been done is essential to ensuring that we can take advantage of the benefits that have been generated and deliver enhanced responses in the future. The WHO defines digital health as a broad umbrella term including eHealth (including mobile health) as well as new disciplines such as [the] application of sophisticated computing sciences in 'big data,' genomics, and artificial intelligence (10). For this study, themes were created in reference to the WHO classification of digital health interventions (11): “client consultations and health information dissemination, citizen-based reporting (mobile apps), on-demand information (national hotlines) and telemedicine (telehealth).” Virtual models of PHC, on the other hand, implement the WHO framework for integrated people-centred health services (IPCHS) by integrating care at the primary-secondary interface (e.g., between GPs and specialists), integrating health and social care (e.g., between primary care, allied health, and social services), and orienting care provision around people's needs (i.e., people-centred) (12).
Previous studies concentrated exclusively on short-term adjustments to deliver PHC via DHTs and on the early days to months of the COVID-19 outbreak, resulting in less coverage of the literature. Our study, on the other hand, is new in the sense that it covers the entire pandemic's peak years (i.e., 2019 to 2021) and aims to stimulate long-term thinking about how to make DHT more inclusive, educative, and satisfying to people's needs, whether under normal conditions or during outbreaks. It also covers the necessity for long-term planning considering new difficulties that arose as a result of the use of DHTs during the COVID-19 crisis, such as hospital hacking and other unlawful cyber-attacks on medical centres and medical technology.
A systematic review was conducted by searching the Medline database via PubMed, Scopus, and Google Scholar as well as a broad internet hand-search for relevant grey literature and the refences of included studies. The central review question was "how has digital health technology (DHT) evolved to provide PHC in the midst of the COVID-19 pandemic?" To better answer the overall question, we also derived two questions. The first (RQ1) was PHC's response and adaption to COVID-19 with a focus on DHTs, and the second (RQ2) focused on what DHTs were used for. Key terms were derived from three major concepts: "primary health care", "digital health" and "COVID-19". Then, for each concept, related key terms were used (see the supplemental materials, Table S1). Studies were included according to requirements (Table 1), which included content addressing the above central research question, published in English between December 2019 and December 2021.
Inclusion criteria | Exclusion criteria |
---|---|
♣ Studies describing digital health technology (DHT) to provide PHC during the COVID-19 pandemic ♣ Full texts ♣ Publications in English language ♣ Dates limits: December 2019 to December 2021 | ♣ Studies without a focus on the COVID-19 pandemic ♣ Studies with lack of focus on PHC ♣ Conference abstract ♣ Other languages |
The study used a six-step iterative process for thematic content analysis and synthesis: i) getting to know the data; ii) assigning a preliminary code to the data to describe the content; iii) searching for patterns or themes; iv) themes review; v) finalizing themes; and vi) generation of a report. The overall results of the study were reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA).
Expert consultation was also included as part of the methodology. The purpose of consultation, as is consistent with other (review) researchers (13), was to ensure obtaining additional sources of information, viewpoints, meaning and relevance to the scope of the research. Preliminary results were consulted with experts in health policy, primary health care, and more. Most of the experts consulted are members of organizations providing policy responses to the COVID-19 crisis, such as ASPHER, the WHO Regional Office for Europe, the COVID-19 Health System Response Monitor, and the European Observatory on Health Systems and Policies.
There were 172 documents found after searching databases (PubMed (n = 18), Scopus (n = 21), and Google Scholar (n = 133) (see the supplemental materials, Tables S1). The overall number of papers included in the synthesis was 46 (Fig. 2), with 40 being journal articles (12, 14–52), and six being grey literature (53–58). 38 of the 40 journal papers were retrieved from databases, and two were found by scanning through the references of the articles included.
The six documents added from manual internet searches included a book (53) about why health tech started to transform public health during COVID-19, with key illustrations of changes in PHC thanks to telemedicine and AI, wearables, social media, and digital therapeutics; two book Chaps. (54, 55) about DHTs helping rapid healthcare service shift due to the COVID-19 pandemic; one working paper (58) about empowering the PHC workforce to make the most of the digital revolution during COVID-19; and two reports (56, 57) about the PHC and the rise of DHTs during the COVID-19 pandemic.
To respond to the first research question (RQ1) of our study about how PHC responded and adapted to COVID-19 with a focus on DHTs, around 19 bigger classes of themes were recorded (Table 2). The top two of these 19 classes included the eHealth category, which comprised things like telehealth, e-prescription, and electronic health records; and the mHealth category, which included many subcategories such as apps on personal phones and mobile electronic records linking patients with PHC professionals. Generally, however, e-prescription, e-referral, digital sensors, wearables, e-mental health, telepsychiatry, telemedical stethoscopes, telemedical ECGs, telemonitoring, teleconsultation, among other DHTs, were extensively adopted in response to the coronavirus pandemic. Furthermore, big data and other DHTs, such as check-in kiosks, emails, online patient portals, self-management home monitoring devices, and chatbots, were also noted.
Table 2. Thematic synthesis of reviewed literature: first research question (RQ1)
RQ1: PHC response and adaption to COVID- 19 with a focus on DHTs
Key themes | Reference |
---|---|
mHealth: App-based telemedicine, mobile telemedecine, call centers, telephone-based care, SMS appointment reminders, call helplines, mobile electronic patient records, mHealth for medication adherence, mHealth for health surveys, mHealth for surveillance and monitoring, mHealth for vital signs checks, national hotlines | (12,14–21,25,36,47,49–52,54,59) |
eHealth: telehealth, telemedecine, e-prescription, e-referral, e-Mental health, telepsychiatry, clinic-based telehealth, telehealth visits | (17–24,26,48,51,54) |
Devices: wearables, wearable health devices, portable electrocardiograms, telemedical stethoscopes, telemedical ECGs, remote monitoring devices | (25,26,36,47–52,59) |
Digital tracing | (27,28) |
Testing, self-testing (self-screening) | (29,30) |
Websites, Platforms, Trials Platform | (24,31–35) |
Monitoring: telemonitoring; home monitoring, remote monitoring, remote patient monitoring, remote monitoring systems, online monitoring | (12,15,16,18,25,35–38,47–49) |
TeleConnect | (39) |
Digital health literacy | (40–42) |
Consultations: tele-consultation, virtual consultations, video consultations | (12,14–16,25,26,36,37,42,47,48,50–52,59) |
Sensing: Digital sensors, laboratory-on-a-chip’ devices | (25,38,48,50–52,59) |
Internet of Things (IoT) | (38,54) |
Artificial intelligence (AI) | (25,36,47–52,59) |
Big data | (38,54) |
Geospatial technology: geospatial reporting systems, geospatial moinitoring, geospatial patient location, trends analysis. | (43) |
Others: check-in kiosks, emails, online patient portals, self-management home monitoring devices, chatbots | (25,48,50–52,59) |
To respond to the second research question (RQ2) about what DHTs were used for in PHC during the COVID-19 pandemic, we identified 20 areas of use, which were then grouped into five main areas (Table 3). First, DHTs were used to support the provision of PHC health services. This included using DHTs to practice general care (teleconsultations, diagnosis, testing, etc.), to manage patients with chronic conditions, mental health care, telehealth visiting options, and digitally link physicians and bring the healthcare system closer together. Second, DHTs were used for communicating, informing, and educating (literacy) roles. This comprises behaviour change promotion (e.g., to combat vaccine hesitancy) and digital health literacy. Third, DHTs were used for monitoring and surveillance purposes, such as monitoring patients’ symptoms and disease diffusion. Fourth, DHTs were used for vaccination and drug issues, such as e-prescription and control of undesired effects. The fifth use of DHTs was to enhance system decision-making for proper follow-up of ongoing PHC interventions and policy change when needed.
Table 3. Thematic synthesis _ second research question (RQ2)
RQ2: What DHTs were used for during the COVID-19 pandemic
Reference | Main areas | Subareas |
---|---|---|
(12,14–16,20,22–27,29,30,35–39,42,44,47,48,50–52,54,59) | SUPPORTING PROVISION OF HEALTH SERVICES | 1. general practice for care provison (tele consultations, diagnosis, testing, etc) |
2. chronic diseases management | ||
3. mental health illnesses | ||
4. management (e.g: telepsychriatry) | ||
5. telehealth visits 6. digitally connecting physicians across the health care system | ||
7. digitally mediated delegation in team-based primary care | ||
8. employing AI for infection detection and treatments | ||
(21,31,40–42,45,59) | COMMUNICATING, INFORMING, AND EDUCATING (LITERACY) | 9. Communicating information on COVID-19 |
10. Behaviour changes promotion (infection control, limiting inaccurate information spreads, combating vaccine hesitancy, etc) | ||
(12,15,33–38,47–49,16,18,24,25,27,28,31,32) | MONITORING AND SURVEILLANCE | 11. patients’ monitoring and surveillance |
12. symptoms monitoring | ||
13. controlling disease diffusion | ||
14. tracing | ||
15. enforcing isolation, self-isolation and quarantining | ||
(25,42,46,48,50–52,59) | VACCINATION AND DRUGS | 16. vaccine roll-out |
17. e-prescriptions | ||
18. controlling adverse reactions | ||
(35,49) | PHC SYSTEM DECISON-MAKING | 19. tracking impact of interventions |
20. policy decisions |
PHC practice has been impacted by the ongoing COVID-19 pandemic in many dimensions. Digital technologies, on the other hand, have evolved and adapted as a result. Telemonitoring, apps, wearable devices, and artificial intelligence are all examples of this.
Previously, digital technology acceptance and implementation in PHC had been difficult and delayed (60–62), but COVID-19 appeared to open new doors and accelerate adoption rates. Primary care providers (PHCPs) or general practitioners (GPs) depended heavily on digital DHTs to continue providing care during the COVID-19 epidemic. We found that DHTs allowed them to provide a wide variety of services, from diagnosis to treatment and palliative care, as well as preventative and vaccine drives. In addition, DHTs were utilized by GPs to increase the number of non-COVID-19 consultations and referrals to secondary care (63) that would have been otherwise dismissed due to COIVDI-19's early responses, such as cancelling non-urgent treatment, lockdowns, and so on.
Due to huge demand for other COVID-19 commitments, primary care centres and offices were frequently understaffed. As a result, different and inventive solutions were required in order to ensure that patients received sufficient care. Thus, DHT use in primary (and secondary) care has risen at previously unheard-of rates since then (64, 65). In the early days of the pandemic, an increase in the usage of remote consultations in PHC was extensively noted. In April 2020, for example, 64–80% of PHCPs in the United Kingdom and the Netherlands used video consultations, 13% used telemonitoring, and 73% used electronic asynchronous consultations (66). The usage of DHTs in hospitals appeared to be growing much more. The utilization of video consultations has increased by 8729% at one academic hospital in New York (67).
Remote monitoring apps for suspected or confirmed COVID-19 patients have equally evolved in hospitals, in addition to video consultations. The COVID-19 box is an example of a home monitoring system that allows patients to check their vital signs three times a day and have daily video chats with the hospital (65). In family medicine, the remote follow-up of patients at high risk of worsening with moderate or severe COVID-19 has brought added value. In this case, unnecessary visits to the emergency room were avoided, and recovery at home was facilitated instead. In remote patient management programs, systems incorporating the collaboration of primary and secondary health care professionals (TeleConnect, for example) have evolved (68). This has a lot of potential since it not only connects patients and physicians, but also physicians among themselves. These technologies either connect PCPs between themselves or with specialists, a habit that was being done in person before the COVID-19 pandemic. These vital connections are critical to patient care, facilitating care coordination and improving the patient's managed care. Furthermore, it could allow patients to stay at home longer while still receiving all the care they require.
Digital sensors were among the DHTs that were used for a variety of applications (38), including chronic condition management, diagnosis, and testing, among others. Many examples exist that show how sensors developed during the COVID-19 era have the ability to revolutionize how current and future PHC care is delivered. For example, a sensor created at Johns Hopkins University (69) can, for example, revolutionize virus diagnostics (i.e., virus testing). During early testing, the sensor detected SARS-CoV-2 in saliva samples with 92% accuracy, which was comparable to PCR assays. The sensor was also extremely effective at detecting the presence of other viruses, such as H1N1 and Zika. Researchers have also demonstrated that this sensor, which requires no sample preparation and little operator skill, has a strong advantage over conventional testing methods, particularly for population-wide testing. It has been shown to overcome the limitations of the two most common forms of COVID-19 tests, namely the PCR and rapid tests. Its key novelty is that it is a label-free technology, which means it does not require any additional chemical modifications such as molecular labelling or antibody functionalization. The latter implies that this sensor could be used in wearable devices in the future.
Digital health literacy is another key aspect of DHT use that has been observed in the COVID-19 pandemic. Digital health literacy played an important role during the COVID-19 pandemic in Pakistan, helping to improve maternal, child, and family health in primary healthcare settings in disadvantaged areas (40). It has also helped to improve patient safety and referral to other health and social issues. Community healthcare workers were also valuable in this process by using smartphone and internet-based digital health literacy initiatives to empower disadvantaged women. Research has shown that literacy and awareness-raising interventions in primary health care settings are more beneficial to underserved women in other areas of maternal and child health, such as nutrition and food security, chronic disease management and multimorbidity, and mental health counselling (40). Moreover, literacy in digital health interventions for patients can, for example, provide skills in short message systems (SMS) for cardiac patients, provide skills in mobile services for patients with diabetes, provide skills in Mobile devices that allow patients to access online consultations from a physician. Other skills that could be improved include interventions that empower patients to provide better information needed by healthcare providers and for better record-keeping and management of patient information.
Briefly, digital health literacy shares exactly two wider visions with regular health literacy, both from a clinical and public health perspectives, across the three domains of health: health care, disease prevention, and health promotion. These are individual skills regarding health information. That is, information that enhances preferred actions in the care relationship between a "patient" and their "caregivers". This therefore defines a clinical vision. Furthermore, this encompasses a broader set of cognitive, social, and civic skills. These skills enable a patient to use information and public services, to gain greater control over his or her own condition(s) (i.e., a patient gains understanding of his or her illness), and, finally, to make decisions to solve community health problems (i.e., a patient participates in collaborative efforts to find solutions to community health issues).The latter defines a public health vision that is considered a key element in decision-making, health promotion, and preventing ill-health. Importantly, patients access, understand, evaluate, and apply skills related to using health information. This illustrates exactly the skills aimed at strengthening the promotion of self-care and self-management of one’s health. All of these are very important because the individuals who have acquired them can use information that could improve their health. S/he would understand, for example, why it is important to use a face mask for COVID-19, to maintain social distance, to take medications as prescribed by a healthcare provider, and so on. This would reduce the gap in information between the patient and her/his care provider (i.e., reduce information asymmetry), which would help to better manage the patient's health. In other words, it will enhance information inclusion from the patient's perspective. Therefore, the patient could, for example, determine, on the basis of the packaging of a pharmaceutical product, how often this product should be taken per day. S/he would also be able to understand what her/his doctor says, and s/he would be able to find information about her/his disease. In this case, the patient would become a good health care partner. To reiterate, improving digital health literacy would not only be a potential solution for successfully embracing digital technologies in healthcare, but it would also allow patients to be aware of and own their health conditions, allowing for better partnerships in delivering health care for both individuals and society as a whole.
Overall, DHTs were widely used during the COVID-19 pandemic, and they showed the potential to improve care (including health-care quality (70–73)). Their promising applications are still being explored. Thus, we need to make sure we don't miss out on the chance provided by COVID-19 to apply DHTs in our daily health care practice.
On the other hand, despite the scope of our study not being focused on the limitations of DHs or why the healthcare sector has been reluctant to accelerate the use of DHT in the past, research claims that healthcare has been slow to adopt digital technologies, while their proliferation has revolutionized many other industries by increasing efficiency and effectiveness (60). Healthcare organizations, particularly physician practices, have been noticeably slow to adopt such technologies. Other researchers have generally looked at potential barriers to DHT use in the past (74–77), especially telehealth (78), but new specific negative concerns have emerged during COVID-19. To mention a few new issues (only the more immediate and illegal aspects): (i) hackers attacking hospitals, clinical analysis centres and medical cyber centres for extorting money, capturing patient data, and preventing clinical activity; (ii) blackmailing people due to clinical data disclosure; and (iii) the threat of introducing the virus into electronic medical devices. We recommend carrying out thorough research of the new negative effects of DHTs that appeared in the COVID-19 era.
The COVID-19 pandemic has influenced how DHTs are perceived and used in the PHC community. The digital revolution in health care has been accelerated. Despite the unwelcome trigger, the pandemic has led PHC providers and hospitals to use DHTs more extensively. Although there is no one-size-fits-all answer to the challenges facing PHC nowadays, the application of DHTs is one potential solution. We believe it is necessary to further stimulate the application of DHT with evidence, making it inclusive, educative, and more satisfying to people’s needs, whether in normal circumstances or during outbreaks. We, therefore, recommend the following considerations to improve the delivery of PHC in the future:
If we have to grasp the DHT opportunity in healthcare properly, digital health literacy should be reinforced as it can be a potential barrier for both providers and users (patients).
Other vulnerable groups of people (42), such as immigrants, the elderly, and women, as well as racial and ethnic disparities (79), should be tactically targeted due to the increased risks of digital exclusion (mainly due to worsening gaps in digital health literacy, along with other compounding issues, including language, financial, and difficulties in social acceptance and integration).
As highlighted previously, DHTs (e.g., sensors and wearables) are already being used in multiple scenarios related to chronic disease management at the PHC level (38). As a result, their potential benefits should be continued after the pandemic has passed, because chronic diseases have been, are, and will undoubtedly continue to be a burden on healthcare systems. In this regard, DHTs may alleviate pre-existing pressure as a result of the latter.
The PHC context integrates multiple disciplines into cohesive teams. The pandemic has prompted or accelerated remote patient management programs, such as TeleConnect (39), which allow collaboration (e.g., between primary and secondary health care professionals). These technologies would make it easier for PCPs to work together or with specialists without having to rely exclusively on in-person collaboration. As such, this could potentially allow patients to be treated at home while still getting nearly all the care they need.
(To this end,) these vital connections between various levels of care provision would be essential for providing coordinated care for patients, facilitating transitions between care settings, and improving the patient's experience with their managed care.
With the reduced number of in-person visits during the pandemic, virtual services such as remote monitoring (38, 49) have shown significant value. To proactively adapt and expand telemonitoring programs in the changing conditions of an increasingly virtualized healthcare system, they should revisit the scope and expectations of telehealth interventions, streamline virtual patient onboarding processes, and personalize patient information collection to build stronger virtual relationships and a more comprehensive assessment of patient safety.
Some novel care models have evolved to address innovative solutions to tackle medical undersupply because of a shortage of human resources in healthcare (medical professionals, for example), as well as demographic and structural constraints. Medical delegation and team-based primary care (26) appear to be a potential strategy to address these issues; however, this will require strong but smoother communication structures and mechanisms to reassure that patients and caregivers are receiving a delegated task for a therapy-related duty. Thus, these evolutionary (if not revolutionary) processes could be made more productive and efficient by using DHTs.
Should the big data generated by DHTs be used to improve future PHC research and development to deliver enhanced patient care, then decentralized and specialized professionally led primary care research centres (and possibly research networks) should be established to stay in the loop of medical research ethics and deontologies. Although it appears to be automatically stored in health care system repositories, this type of data requires extra protection (80, 81) and hence cannot be gathered and used routinely. Specialized research entities (in addition to the current research clearance bodies) will be needed at multiple levels, from the national level to the local level.
Finally, before DHTs are fully integrated, a significant amount of research will be required, and they should be designed to suit their function—improving a patient’s care rather than exacerbating the problem. Teleconsultation (or telemonitoring) for a patient with psychiatric issues, for example, might not be implemented in the same way as it should be for patients in internal medicine. Telepsychiatry would almost certainly be feasible and acceptable for some people (perhaps those with minor issues) but would probably impair the outcomes for others (those patients with advanced mental health problems, for example).
Our research revealed that DHTs have potential in the current and future PCH industry, whether in health emergencies or in normal conditions. Yet, a few more things need further research. First is regulation, where the legal framework and licencing of digital health tools. Second, are the quality issues, such as guidelines on the use of digital health and skills and training. The third is technical aspects such as standards for digital health tools, including interoperability, infrastructure, and platforms. Last but not least, is the financial perspective, such as payment for digital health services and incentives for adoption.
The study only included papers written in English, and only three databases were searched. Furthermore, the study period was restricted to the peak years of the COVID-19 pandemic, namely 2019 to 2021.
The digital technologies that emerged during COVID-19 were essential for PHC delivery. In this context, DHTs are commonly used for a variety of purposes, including virtual care services, providing clinical support, monitoring quality of care, and mapping, and monitoring the spread of the coronavirus, as well as tracking supplies of drugs and vaccines. These DHTs have already opened up a wealth of possibilities and opportunities for shaping the future of PHC. Their integration into clinical support tools and referral systems can help care coordination and ensure its continuity across primary, secondary, acute, and aged care services. They can help to prevent duplicate care processes and improve communication between providers themselves and between patients. Additionally, they can help to avoid unplanned hospitalizations and visits to hospitals. DHT's power to catalyse change is significant, so it is important that people are well-educated about digital health (digital health literacy), policy and practice are enhanced, and communication is effective. DHT also provides the potential to address some of the shortages in the health care workforce which are facing health systems internationally. For this to be a reality there will be a need for cultural change in health care, as well as investment in training and in new technology. Health systems should be committed to the goals of PHC and its values, and thus DHT inclusiveness and equity should be ensured to keep up with changes that are necessary to provide care for all. Furthermore, there should be appropriate caution when using DHT approaches to ensure that the benefits are realized, and any potential harms are avoided.
Digital Health Technology
Primary Health Care
Primary Care Physician
General Practitioner
Integrated People-centred Health Services
Universal Healthcare Coverage
Research Question
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
Association of Schools of Public Health in the European Region
World Health Organization
Ethics approval and consent to participate: Not applicable
Consent for publication: Not applicable
Availability of data and material: Not applicable
Competing interests: The authors declare no conflict of interest.
Funding: This research received no external funding.
Authors' contributions: Conceptualization, C.N., H.L and J.M.; methodology, C.N.; data acquisition, CN, formal analysis, C.N; writing—original draft preparation, C.N.; writing—review and editing, H.L., and J.M.; visualization, C.N., and H.L.; supervision, H.L. and J.M. All authors have read and agreed to the published version of the manuscript.
Acknowledgements: Not applicable
Authors' information:
JM is President of the Association of Schools of Public Health in Europe (Brussels, Belgium); Honorary Professor of Public Health at the University of Wolverhampton; and Visiting Professor of Public Health at Chester University.
HL is Professor and Public Healthcare Researcher at the Institute of Health Sciences' Public Health Unit (Universidade Católica Portuguesa); Coordinator of the Health Education Group at the Comité mondial pour les apprentissages tout au long de la vie (CMAtlv), partenaire officiel de l'UNESCO (Paris, France); Senior Board of the COVID-19 Task Force at the Association of Schools of Public Health in the European Region (Brussels, Belgium); and President of the commission on quality in health in Portugal.
CN is a Doctor of Medicine and researcher, with post-graduate education in European public health, specializing in the Governance of Health Systems in Transition.